As of 2025-05-19, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -144.52. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 576.35 mil USD. MRVI's TTM EBITDA according to its financial statements is -3.99 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 16.6x | 13.8x |
| Forward P/E multiples | 18.9x - 26.6x | 23.2x |
| Fair Price | (0.46) - (0.42) | (0.45) |
| Upside | -121.9% - -120.2% | -121.6% |
| Date | EV/EBITDA |
| 2025-05-16 | -144.52 |
| 2025-05-15 | -135.58 |
| 2025-05-14 | -136.86 |
| 2025-05-13 | -141.97 |
| 2025-05-12 | -145.80 |
| 2025-05-09 | -136.86 |
| 2025-05-08 | -142.60 |
| 2025-05-07 | -145.80 |
| 2025-05-06 | -140.37 |
| 2025-05-05 | -145.80 |
| 2025-05-02 | -142.60 |
| 2025-05-01 | -140.05 |
| 2025-04-30 | -139.41 |
| 2025-04-29 | -142.60 |
| 2025-04-28 | -138.77 |
| 2025-04-25 | -141.01 |
| 2025-04-24 | -142.60 |
| 2025-04-23 | -144.52 |
| 2025-04-22 | -133.67 |
| 2025-04-21 | -123.45 |
| 2025-04-17 | -123.45 |
| 2025-04-16 | -120.26 |
| 2025-04-15 | -120.89 |
| 2025-04-14 | -123.45 |
| 2025-04-11 | -127.28 |
| 2025-04-10 | -124.09 |
| 2025-04-09 | -134.30 |
| 2025-04-08 | -130.47 |
| 2025-04-07 | -137.50 |
| 2025-04-04 | -134.30 |
| 2025-04-03 | -144.52 |
| 2025-04-02 | -151.54 |
| 2025-04-01 | -148.35 |
| 2025-03-31 | -151.54 |
| 2025-03-28 | -161.12 |
| 2025-03-27 | -160.48 |
| 2025-03-26 | -161.76 |
| 2025-03-25 | -157.29 |
| 2025-03-24 | -153.46 |
| 2025-03-21 | -155.06 |
| 2025-03-20 | -163.68 |
| 2025-03-19 | -165.59 |
| 2025-03-18 | -175.17 |
| 2025-03-17 | -179.00 |
| 2025-03-14 | -166.87 |
| 2025-03-13 | -164.95 |
| 2025-03-12 | -177.08 |
| 2025-03-11 | -179.00 |
| 2025-03-10 | -193.05 |
| 2025-03-07 | -199.43 |